Notes on consultation and implementation in the three ICH Regions

First Page		Document Content
Date: 2015-03-19 04:53:54 Research Pharmaceutical industry Pharmaceuticals policy Health Canada Health in Canada European Medicines Agency Food and Drug Administration Medical device Ministry of Health Labour and Welfare Medicine Health Clinical research		Notes on consultation and implementation in the three ICH Regions Add to Reading List Source URL: www.ich.org Download Document from Source Website File Size: 10,42 KB Share Document on Facebook

	Country of Origin as a Modifier of the effect of Generation and Length of Residence on the Mental Health Outcomes of Immigrants to Canada by Shirin Montazer DocID: 1xUDn - View Document
	2013 Annual Report HARNESSING A NEW ERA OF PARTNERSHIPS AND NETWORKS IN HEALTH INNOVATION THANK YOU TO OUR LEAD SPONSOR CANADA’S RESEARCH-BASED PHARMACEUTICAL COMPANIES DocID: 1vr6Q - View Document
	Developing novel NMDA receptor positive modulators as neuroprotectants Yu Tian Wang Djavad Mowafaghian Centre for Brain Health and Department of Medicine/Neurology, University of British Columbia, Vancouver, Canada The DocID: 1vnMG - View Document
	Occupational Health & Safety for Federally Regulated Workplaces The federal health and safety legislation is commonly referred to as Canada Labour Code Part II and regulations under the Code. The Canada Labour Code also DocID: 1vn7y - View Document
	PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno DocID: 1vlwz - View Document